Bruce Hellman

Co-Founder & Chief Patient Officer - uMotif

Founder of uMotif - a modern patient-centric platform for eCOA/ePRO and eDiary data capture for Clinical Trials and Real World Studies.

Bruce Hellman


  • Tuesday - May 28, 2024 - 08:50

    Welcome Address & Chairperson’s opening remarks

    Begin your conference journey with a warm welcome from our esteemed Chairperson

  • Tuesday - May 28, 2024 - 17:30

    Executives Discussion and Debate: Empowering drug discovery and development: the AI and Machine Learning revolution?

    • How pharmaceutical companies are adopting AI to discover new drugs and improve existing ones, and the impact this is having on their R&D strategies
    • How AI is not just a tool for research but is reshaping business models, leading to collaborations with tech companies, the rise of AI-driven biotech firms, and changes in investment strategies
    • Strategies to maximize AI & ML's impact in drug discovery and development
    • Mitigating risks and uncertainties in drug development through AI. Explore how AI is being used to navigate the complexities of both early-stage discovery and late-stage clinical trials

  • Wednesday - May 29, 2024 - 08:50

    Welcome Address & Chairperson’s opening remarks

    Start the second day with insightful remarks from our Chairperson


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now